curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

by palligoelme@gmail.com | Oct 28, 2025 | Clinical Trials

​ Conditions: HFrEF – Heart Failure With Reduced Ejection Fraction; HFpEF – Heart Failure With Preserved Ejection Fraction; Group 2 Pulmonary Hypertension Interventions: Drug: JK07 Sponsors: Salubris Biotherapeutics Inc Not yet recruiting Conditions: HFrEF...

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

by palligoelme@gmail.com | Oct 28, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: survodutide Sponsors: Boehringer Ingelheim Not yet recruiting Conditions: Healthy Interventions: Drug: survodutide Sponsors: Boehringer Ingelheim Not yet recruiting 

Boosting Olfactory and Sensory Training Study (BOOST)

by palligoelme@gmail.com | Oct 27, 2025 | Clinical Trials

​ Conditions: HIV (Human Immunodeficiency Virus) Interventions: Other: Standard Smell Training Group; Other: Overnight Diffuser Grou Sponsors: University of Alabama at Birmingham Not yet recruiting Conditions: HIV (Human Immunodeficiency Virus) Interventions: Other:...

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

by palligoelme@gmail.com | Oct 27, 2025 | Clinical Trials

​ Conditions: Adjustment Disorder; Anxiety Disorder; Depression; Hematopoietic and Lymphoid System Neoplasm; Malignant Solid Neoplasm; Cancer Interventions: Other: Questionnaire Administration; Other: Virtual Reality (VR) Intervention Sponsors: Mayo Clinic...

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

by palligoelme@gmail.com | Oct 27, 2025 | Clinical Trials

​ Conditions: Dyslipidemia; Insulin Resistance Syndrome; Hypertension; Inflammation Chronic; Obesity & Overweight Interventions: Behavioral: Step counts for predictable changes in body weight/compositon and cardiometabolic risk Sponsors: Kennesaw State University...
« Older Entries
Next Entries »

Recent Posts

  • Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell Lymphoma
  • Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
  • A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)
  • Effect of Autologous Serum-Soaked Paper Patch vs. Traditional Dry Paper Patch on Tympanic Membrane Perforations
  • Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®